LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced its financial results for the fourth quarter and fiscal year 2024, ...
MyChesCo on MSN7h
Savara Completes BLA Submission for MOLBREEVI to Treat aPAPLANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the completion of its Biologics License Application (BLA) submission ...
Tempest Therapeutics (TPST)’ treatment of familial adenomatous polyposis was granted orphan designation by the FDA, according to a post to the ...
FDA and EMA discussions completed to support a potential accelerated approval path in both US and EU Orphan Drug Designation for PCNSL granted in both US and EU Management ...
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, ...
Non-profit organisations provide an alternative to rescue stalled orphan drugs for biotechs struggling against a lethargic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback